17 results
424B3
CTCX
Carmell Corp - Ordinary Shares
5 Jun 24
Prospectus supplement
6:06am
of products and packaging, brand awareness, perceived value and quality, innovation, in-store presence and visibility, promotional activities, advertising … , labeling or design deficiencies, packaging defects or other deficiencies or failures to comply with applicable regulations. Product defects or other errors
8-K/A
EX-99.2
9payrf7vgp0l851
25 Oct 23
Unaudited Condensed Financial Statements
4:02pm
8-K
EX-10.1
kh5guza4
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
424B3
f5ajk9h
23 Jun 23
Prospectus supplement
4:47pm
8-K
EX-1.1
fkp3r t4ommszafom
29 Jul 21
Alpha Healthcare Acquisition Corp. III Announces Pricing of $150 Million Initial Public Offering
4:07pm
- Prev
- 1
- Next